A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity. [electronic resource]
Producer: 20161017Description: 47-57 p. digitalISSN:- 1029-2330
- Aminoglycosides -- administration & dosage
- Animals
- Antibiotics, Antineoplastic -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antigens, CD19 -- immunology
- Apoptosis
- Cell Line, Tumor
- Cell Survival
- Dose-Response Relationship, Drug
- Drug Carriers
- Enediynes -- administration & dosage
- Female
- Heterografts
- Humans
- Lymphoma, B-Cell -- physiopathology
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Recombinant Fusion Proteins -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.